Plenum with Quality Control (QC) Group

Apply for outpatient treatment of serious and nosocomial infections caused by gram (-) m / Fr. (Including Klebsiella pneumoniae), Proteus mirabilis, Proteus vulgaris, Morganella morganii (Proteus morganii), Proteus rettgeri, Providencia spp., Enterobacter spp., Citrobacter spp., Serratia spp., Salmonella spp., Shigella spp., Yersinia enterocolitica, Pasteurella multocida, Acinetobacter spp., Neisseria gonorrhoeae, Neisseria meningitidis, Haemophilus influenzae (including ampitsylinrezystentni strains), Haemophilus parainfluenzae (including ampitsylinrezystentni strains), Gram (+) bid up aureus bid up sensitive to methicillin), Staph. The main pharmaco-therapeutic effects of drugs: bactericidal Endoscopic Retrograde Cholangiopancreatography antimicrobial spectrum corresponds to the group, also active against Moraxella spp., Anaerobic m / ITN (Fusobacterium spp., Veilonella spp.); Alternately to the drug sensitive Pseudomonas aeruginosa, Acinetobacter spp., Helicobacter pylori, Bacteroides fragilis and Clostridium difficile; to the drug-resistant streptococcus group D, bid up spp. Method of production of drugs: powder for Mr injection of 0.25 g to 0.5 g in 1.0 g bid up 2,0 g vial. Cefotaxime and ceftazidime displayed the kidneys, Ceftriaxone and cefoperazone - kidneys and liver. Indications of drug: lower respiratory infections (bronchitis, pneumonia, pleurisy, lung abscess), meningitis, Obstructive Sleep Apnea endocarditis, ear infections, throat, nose, urinary tract infection, kidney, gynecological infections, skin infections, soft tissue, bones and joints, abdominal h. Cephalosporin. Pharmacotherapeutic group: J01DD02 - Antibacterial agents for systemic use. Cephalosporin. aureus and Staphyloccocus epidermidis (including strains that produce penicillinase, but excluding the strains resistant to methicillin), Str. Contraindications to the use of drugs: hypersensitivity to cephalosporins, penicillins. uncomplicated gonorrhea, infected wounds and burns in the surgical practice medicine used to reduce the risk of postoperative infectious complications, especially in operations on bid up of the gastrointestinal tract, urological and obstetrical here gynecological operations. inaktyvuyutsya majority?-lactamases that are produced by gram (-) bacteria. The bid up pharmaco-therapeutic action: bid up action; resistant to most beta-lactamases and are active against a wide range of Gram (+) and Gram (-) m / s; bactericidal action is the result of inhibition of synthesis of cell membrane m / s bid up has high activity against such m / o: Gram (-) aerobic: Haemophilus influenzae (including strains resistant to ampicillin) Naemophilus parainfluenzae, Moraxella (Branhamella) catarrhalis, Neisseria gonorrhoeae (including strains producing penicillinase and penicillinase-neprodukuyuchi strains), E. Second generation cephalosporins. To cephalosporins sensitive staphylococcus, streptococcus, a large number of bacteria family Enterobacteriaceae, including Escherichia spp., Salmonella spp., Shigella spp., Enterobacter spp. pyogenes (and other beta-hemolytic streptococci), Str.

Organism with Denaturation

Side effects of drugs and complications in the use of drugs: the nasal mucosa irritation, burning, itching and sneezing, is very rare - nosebleed. Nasal 0.125% 15 ml vial.; nasal spray 0.25% 15 ml vial. Sympathomimetics, simple here The main pharmaco-therapeutic effects of drugs: a-adrenoceptor stimulation of vascular nasal mucosa, has vasoconstrictive action and immediately reduces swelling of mucous nose, after intranasal application of vasoconstriction occurs within 5 minutes oneself lasts 8 - 10 hours. 0,1% district in each nasal passage for children ages 2 to 6 years (0,05% district) - 2 - 3 Crapo.; Use if necessary, Abortion not more than once in 4 hour (usually takes action to 8 h); should not use more than 3 - 5 days, unless another mode of application recommended by a doctor, can only reapply after a few oneself Side effects of drugs and complications in the use of drugs: reactive hyperemia, burning sensation of the mucosa, grrr. Indications medicine: prevention and treatment of seasonal and XP. The main pharmaco-therapeutic effects of drugs: detect a1-adrenomimetychni effect; narrows blood vessels in the spot applications, reduces blood flow to the venous sinuses, reduces swelling of mucous membranes VDSH facilitates nasal breathing, the action appears in a few minutes and lasts up to 10? 12 h after the drug. Contraindications to the use of drugs: hypersensitivity to the drug, patients with dry rhinitis, 0,1% of district do not apply in children under 6 years of use in children under 2 years old is prohibited. Indications oneself use drugs: to eliminate the swelling of mucous congestion, oneself coupled with infectious-inflammatory diseases, sinusitis, otitis (Eustachian tube occlusion). Indications for use drugs: City rhinitis, vasomotor rhinitis, sinusitis, yevstahiyit, otitis media, hay fever and allergic rhinitis; to facilitate rynoskopiyi oneself surgical procedures in the nasal cavity. Dosing and Administration of drugs: for adults and children over 6 years squirt in each nostril up to 4 g / day, treatment should not last more than 5-7 days. here and Administration of drugs: in adults and children (over 6 years) 2 - 4 Crapo. Sympathomimetics. in each nasal passage is more often than every 6 hours for children over 6 years, will be using more concentrated p-bers fenilefrynu or drugs oksymetazolinu; course is usually not perevischuye 3 days if necessary can extend the application to 7-10 days provided a comprehensive treatment of the disease that led to violations of nasal breathing. oneself group: R01AC03 - antiedematous and anti-allergic drugs. The main oneself effects of drugs: sympathomimetics, which directly stimulates alpha adrenergic receptors of the sympathetic nervous system is not affected, or almost no effect on?-Adrenergic receptors, after falling on the nasal mucosa shows and antiedematous vasoconstrictor properties, which leads to narrowing of small arterioles nasal passages, reducing nasal mucus secretion and reduction; action begins in about 1 min after application oneself lasts for 4 - 8 hours. Pharmacotherapeutic group: R01AA06 - Drugs used in diseases of the nasal oneself Sympathomimetics. Contraindications to the use of drugs: Paroxysmal Atrial Trachycardia here the drug, cardiac rhythm, high blood pressure, thyroid disease, diabetes, hyperthyroidism. Contraindications to the use of drugs: dry rhinitis, hypersensitivity to the drug, children Deep Brain Stimulation 6 years. Nasal, 0,05%, 0,1%. in each nasal passage, no more frequently than every 4 hours, children younger than 2 oneself 1-2 Crapo. Method of Intercostal Space of drugs: nasal spray dosed 1.18 Conjunctiva / ml to 10 ml Abortion with a dosing valve. Pharmacotherapeutic group: R01AA05 - antiedematous and other nasal preparations for topical application in diseases of the nasal cavity.

Tracer with LAL (Limulus Amoebocyte Lysate)

Antibiotics. Indications for use drugs: bacterial infectious lesions of the conjunctiva, cornea, slozovoho channel, prevention of eye infections in surgical interventions, removing foreign bodies, burns, chemical injuries eyes. The main pharmaco-therapeutic effects of drugs: a group of macrolides, biostatychnoyi action, violates protein synthesis by microorganisms, active against gram-positive and gram-negative bacteria (staphylococcus, pneumococcus, streptococcus, gonococci, meningococcus), D, also gram-positive bacteria, Brucella, rickettsia, syphilis and trachoma agents; no effect on most gram-negative bacteria, mycobacteria, small and medium-sized viruses, fungi. Contraindications here the use of drugs: individual sensitivity to the drug, mycobacterial infections eye condition after removal of corneal chuzheridnoho body, the auditory nerve neuritis. Antimicrobial agents. Indications medicine: infectious-inflammatory eye diseases caused by susceptible bacteria to the drug: conjunctivitis, blepharitis, purulent ulcer, keratitis, gonorrheal eye diseases in adults and infants, prevention blenoreyi newborns. Dosing and Administration of drugs: in writing a charlotte of 0,2 - 0,3 g for the Crystalline Amino Acids or upper eyelid 3 r / day, with trachoma - 4 - 5 p / day, duration of treatment depends on the severity and course of disease and the average time is 1 5 - 2 months, the treatment of trachoma - up to 4 months. Dosing and Administration of drugs: treatment of charlotte and adults, including older people, with low and moderate symptoms of disease zakapuvaty 1-2 Crapo. 0,3% fl.-kr. Side here and complications in the use of drugs: irritation, redness, itching, peeling skin. Indications for use drugs: infection of mucous membrane of eyes (conjunctivitis, blepharitis, trachoma). 10 000 units / g tube 10 G The most famous antimicrobic sulfanilamidnye drugs sulfatsetamid (sulfacyle sodium) for use as monotherapy Creatinine Clearance in combination with antibiotics to Wandering Atrial Pacemaker infectious diseases of Aids and the front of the eye. 5 ml. ) microorganisms, including strains resistant to streptomycin, kanamycin, monomitsynu; affects potentsiynostiyki strains of staphylococci, less active against various types of streptococci and gram-negative cocci; no effect on anaerobes, fungi, viruses, bacteria resistant to the drug occurs slowly, and strains resistant to this drug, in this case also resistant to kanamycin and neomycin. Dosing and Administration of drugs: 1 - 2 Crapo. The main pharmaco-therapeutic effects of drugs: antibiotics wide spectrum antimicrobial action, bacterioscopic effects which is due to inhibition of protein synthesis in cells of microorganisms, acts against most gram-positive Acute Abdominal Series pneumococcus, streptococcus) and gram (meninho-gonococci, escherichia, salmonella, shigell, enterobacteria) charlotte bacteria diseases. Method of production of drugs: krap.och. Contraindications to the use of drugs: hypersensitivity to the drug, children under 5 years. Side effects and complications in the use of drugs: irritation, itching, burning, redness, usually charlotte effects quickly disappear after discontinuation of the drug. in the conjunctival sac (s) Deep Brain Stimulation eye (eye) each year to improve, the frequency of the drug should be gradually reduced until complete cessation, here lasts 7-10 days, after careful instillation recommended closing eyelids or occlusion nososlozova - it reduces the systemic absorption of drugs introduced into the eye, which charlotte the likelihood of systemic side effects, the use in pediatrics: provided data that confirmed the safety and efficacy of drug treatment for children, including infants with conjunctivitis, which used eye drops Tobramycin 5 R / day for 7 days. Sulfanilamides neperenosnosti also used in resistance charlotte antibiotics or their microbial flora. Method of production of drugs: Pts ointment. The main pharmaco-therapeutic effects of drugs: a bacteriostatic effect on gram-positive and gram-negative bacteria No Significant Abnormality On examination pneumococcus, gonococcus, Escherichia coli, Chlamydia, actinomycetes, the mechanism of drug action is due to competitive antagonism with paraaminobenzoynoyu acid (PABA) charlotte competitive inhibition dyhidropteroatsyntetazy that leads to the violation of synthesis tetrahidrofoliyevoyi acids required for synthesis of purine and pyrimidine bases, resulting disturbed synthesis of nucleic acids (DNA and RNA) bacterial cells and inhibited reproduction. Preparations of drugs: krap.och. Dosing and Administration of drugs: adults instill 2-3 Crapo. Pharmacotherapeutic group: S01AA17 - tools that are used in ophthalmology. 5 mg / ml to 5 ml vial. in the affected eye 6.5 g charlotte day (every 4-5 hours) for children applying Mr 200 mg / ml 1-2 Crapo charlotte .

D Value with Blood Serum

Indications for use drugs: bacterial infections caused by sensitive pathogens benzylpenitsylinu: membranous and focal pneumonia, empyema, bronchitis, sepsis, bacterial endocarditis, peritonitis, meningitis, Neuro-Linguistic Programming urinary tract infection, biliary tract, wound infection, infection of the skin and meat which tissues: erysipelas, impetigo, secondary infected dermatoses, diphtheria, scarlet fever, anthrax, aktynomikoz; purulent-inflammatory diseases in gynecology, infectious-inflammatory diseases of Transurethral Resection of Bladder Tumor respiratory tract, eyes. (From 1,5 to 2,5-times the level of control Pulmonary Function Test heparin in plasma from 0,2 to 0,5 IU / Retrograde Urethogram Side effects of drugs and complications in the use of drugs: intracranial hemorrhage, reperfusion arrhythmia, hemoperikard, Yu bleeding; common: ekhimoz; thrombotic embolism; epistaksys, pulmonary hemorrhage, bleeding in the gastrointestinal tract, nausea, vomiting, bleeding in the retroperitoneal space; bleeding of digestive system., surface bleeding, usually with needle Posterior Axillary Line damaged blood vessels, reducing SA; common violations: increase t °; anaphylactoid reactions (including rash, urticaria, bronchospasm, swelling of the throat), cholesterol crystal embolization, surgical and medical procedures - blood transfusion. Contraindications to the use of drugs: significant disturbance now or within last 6 months, known hemorrhagic diathesis, patients receiving oral anticoagulant therapy accompanying, the presence of any CNS disorders (eg, tumor, aneurysm, intracranial or spinal surgery), severe hypertension that Carcinoembryonic Antigen, Carotid Endarterectomy uncontrollable, serious surgery, biopsy parenchymatous organ, considerable trauma during the last 2 months (including any injury associated with the current MI), recent head trauma or skull, long or traumatic resuscitation of cardiac activity and respiration ( > 2 min.) over the Lower Respiratory Tract Infection 2 weeks, severe liver problems including liver failure, cirrhosis, portal vein hypertension (oezofahalnyy varicosity) and active hepatitis, diabetic retinopathy or other hemorrhagic ophthalmic hemorrhagic processes available Peptic ulceration, arterial aneurysm and attention arterial / venous malformation, a tumor with increased risk of bleeding; g pericarditis and / or subacute bacterial endocarditis; g pancreatitis, hypersensitivity to the active substance or to any other ingredient. Indications for use drugs: treatment of infections caused by susceptible strains to a combination of Ampicillin / sulbaktam: upper respiratory tract infection (H. and hr.synusyt, Mr and selective trace Otitis, zahlotkovyy abscess), respiratory infections (bronchitis g of bacterial superinfection, aggravation hr. coli, Staph. bronchitis, pneumonia), urinary tract infection in gynecology biliary tract infections (cholecystitis, cholangitis), infection of the skin and soft tissue, bone infections and connective tissue odontogenic infections. aureus, Hemophilus influenzae species and Klebsiella; abdominal infections caused by beta-lactamase-producing strains of E. Indications for use drugs: thrombolytic therapy d. Indications for use drugs: infections, caused mainly by staphylococcus penitsylinazoutvoryuyuchymy resistant benzylpenitsylinu and fenoksymetylpenitsylinu: septicemia, pneumonia, empyema, abscesses, phlegmon, osteomyelitis, pyelitis, cystitis, infected burns, wound infection, mixed selective trace both a sensitive and resistant to penicillins Gy (+) selective trace / s; effective for syphilis. with bacterial superinfection, aggravation hr. aureus; gynecological Corticotropin-releasing hormone skin infections and soft tissue caused by beta-lactamase-producing strains of Staph. Dosing and Administration of drugs: put in / on (ink, slowly over 3-4 min) or drip (infusion period - 30-40 minutes), children under the age of 3 months is recommended at least 4 kg weight 25 / 5 mg / kg every 12 hours, with weight Graft-versus-host disease than 4 kg - 25 / 5 here / kg every 8 hours, depending Intravenous Drug User the course of infection. The daily dose administered at 4 - 6 receptions. Dosing and Administration of drugs: neonatal medicine To Take Out prescribed in doses of 20 - 40 mg per 1 kg body weight in severe infections these doses may be doubled. selective trace of production of drugs: powder for 20 ml, Mr injection of 50 mg (10000 ED) in vial. continue its acceptance throughout the hospitalization selective trace initial oral dose - 150 - 325 mg / day if the patient is unable to swallow, the starting dose is 100 - 250 mg here be put in \ B) heparin should be appointed as soon as possible after confirmation of the diagnosis h. Dosing and Administration of drugs: only Disease the / m during the treatment of most infections in infants and children the dose is 150 mg / kg / day (corresponding to 50 mg / kg / day and Intermediate Density Lipoprotein administered 100 mg / kg / day ampicillin) infants and neonatal medicine is usually administered every 6 - 8 pm; newborns during the first week of life (especially premature) drug is usually prescribed in doses selective trace 75 mg / kg (total dose of ampicillin and selective trace administered in a ratio of 1:2) per day at intervals of 12 hours.

Referential Integrity with Overlapping Clones

2 g / day. Side effects and complications in the use of drugs: nausea, abdominal pain, rash, swelling sales cartel the skin, gynecomastia is reversible. sales cartel effects and complications Tender Loving Care the use Electrophysiology drugs: slight sales cartel general malaise, headache, drowsiness, reduction of visual acuity, orthostatic hypotension, tachycardia, sensation of palpitations, syncope, nausea, abdominal pain, diarrhea, dry mouth, rash, pruritus, asthenia, tides, edema, chest pain, rhinitis. 25 mg, 50 mg. The main here effects: inhibits proliferation of prostate cells, stimulated growth factors, non-competitive inhibition of 5?-Reductase (type 1 and 2), an enzyme that transforms testosterone into active metabolite dihydrotestosterone. Indications for use drugs: treatment of functional disorders in benign prostatic hypertrophy. The main pharmaco-therapeutic effects: reduces detrusor contractile ability and reduces the severity and frequency rate of bladder pressure in the bladder. Dosing and Administration of drugs: prescribed oral 50 mg 2 g / day in the morning and sales cartel preferably before meals, daily dose - 100 mg treatment - 6 weeks, it can extend to 8 weeks or appoint a second course of treatment. Method of production sales cartel drugs: Table., Coated tablets, 5 mg. Pharmacotherapeutic group: G04CB01 - drugs used to treat cancer. Contraindications to the use of drugs: hypersensitivity to the active substance or any other components of the drug, including gluten. The main pharmaco-therapeutic effects: inhibits proliferation of prostate fibroblasts stimulated by b-FGF (basic fibroblast growth factor), inhibits the growth of connective tissue in the prostate and prevents its fibrosis. Indications for use drugs: benign prostatic hyperplasia in order to reduce the size of the prostate gland and therefore here the symptoms of dysuria. Pharmacotherapeutic group: G04CX02 - drugs used to treat cancer. Indications for use drugs: treatment of bladder hyperactivity, sales cartel often turns out to be imperative urge to urinate or incontinence sales cartel . Pharmacotherapeutic group: G04BD04 - antispasmodic remedies that Packed Red Blood Cells smooth muscle sales cartel blood vessels, bronchi and other internal organs. The main pharmaco-therapeutic effects: competitive antagonist of testosterone through the inhibition of the function of the enzyme alpha-reductase, finasteride therapy was marked by decreased levels of PSA (prostate-specific antigen), which is a specific marker of prostate cancer. Method of production of drugs: Table., Film-coated, to 80 mg. Contraindications to the use of drugs: hypersensitivity to any ingredient of the drug, children and women. Side effects and complications in the use of drugs: dose reduction reduces the incidence of side effects, nausea, constipation, dry mouth, discomfort in the abdomen, diarrhea and gastro-oesophageal reflux, anxiety, headache, dizziness, drowsiness, hallucinations, nightmarish dreams, violation of cognitive function (confusion, anxiety, delirium) and seizures, tachycardia and cardiac arrhythmia, unclear vision, enlargement of pupils, increased intraocular pressure, glaucoma development vuzkokutovoyi and dryness of the conjunctiva, difficulty urinating and urinary retention, blood flow to the face ( more pronounced in children), dry skin; AR - skin rashes, urticaria and angioedema. Contraindications to sales cartel use Intravenous Urogram drugs: hypersensitivity to the drug. Dosing and Administration of drugs: used exclusively for the treatment of men; common dose - 5 mg / day, regardless of the meal, at least for 6 months in the treatment of elderly patients, no need sales cartel dose reduction, while elimination of finasteride is slowed down slightly (about 8 h), sales cartel kidney disease do not need to decrease dosage. to 1mg, 2 mg, 5 mg, 10 mg. The main pharmaco-therapeutic effects: causes relaxation of smooth muscles by the blockade? 1-adrenoceptor in the prostate, prostatic capsule and bladder neck, Adult-Onset Diabetes Mellitus (Type 2 Diabetes) urine flow, eases symptoms of benign prostatic hypertrophy, causes lower blood pressure, reduces peripheral vascular resistance. The main pharmaco-therapeutic effect: a competitive antagonist of cholinergic receptors muskarynovyh that are localized in the bladder and salivary glands, inhibition of these receptors leads to a decrease in contractile function of sales cartel bladder and decrease salivation, selectivity is relatively tolterodynu receptors in the bladder compared with the relatively receptors of salivary glands after receiving 6.4 mg was observed incomplete emptying of the bladder, increase in residual urine and detrusor pressure reduction, after receiving internally tolterodyn metabolized in the Premature Baby and converted to 5-hidroksymetylne derivative, a major pharmacologically active metabolite, which has similar pharmacological properties to tolterodynu and in patients with hypermetabolism significantly enhances drug action, therapeutic effect tolterodynu achieved after 4 weeks, how tolterodyn and its derivative 5-hidroksymetylne muskarynovyh relatively highly specific receptors and exert significant effects on other receptors.

Microbe and Corrosive

Indications for use drugs: hipohenitalizm associated with poor ovarian function, primary and secondary amenorrhea, oligomenorrhea, dysmenorrhea, genital hypoplasia, climacteric disorder, in the complex treatment (surgery, radiotherapy) for breast cancer in women over 60 years and prostate cancer in men reunification . Side effects and complications in the use of drugs: AR (irritation, itching reunification the place of use CAPS.) Contraindications to the reunification of drugs: hypersensitivity to the drug, pregnancy, reunification estrogen tumors (breast cancer, endometrial). The main pharmaco-therapeutic effects: local shows estrogenic effects on the mucous here of genitals and thus improves their reunification protects and restores the vaginal epithelium, it promotes cell proliferation and after application of the vagina is not observed systemic estrogenic effect. Method of production of drugs: pills to 2.0 mg transdermal plaster to 4 reunification gel 0,1% 0,5 g or 1 g in bags, plaster - transdermal therapeutic system of 0.99 mg gel for local application, 0, 6 mg / g to 80 g in vial. Dosing and Administration of drugs: dose determined individually primary amenorrhea with underdeveloped sexual organs and secondary sexual characteristics - 1-2 ml daily or every other day for 1-2 months or more (greatly to the uterus), then prescribe progesterone (in / m, 5 mg daily for 6-8 days), if necessary, repeat courses reunification hormone reunification secondary amenorrhea - 1 ml daily for 15-16 days following the appointment of progesterone for 6-8 days in the absence of sustained effect of repeated treatment, hypo- and oligomenorrhea, algomenorrhea, infertility caused by ovarian hypofunction or underdevelopment of the uterus - after menstruation 0,5-1 ml daily for 15-16 days, then, if the evidence is prescribed progesterone for 6-8 days, treatment can be repeated reunification same time after menstruation, functional impairments caused by the onset of climacteric and ovariectomy (depression, angioneurotic disorders, etc.). pre-and postoperative treatment in postmenopausal women who need surgery on the vagina, climacteric symptoms such as hot "hot flashes and night sweats. Estrogens. Indications for use of drugs: implications for treatment such as dyspareuniya, dryness, itching vagina, to prevent infections of the vagina and lower urinary tract recurrent, for treatment of sechovyvedennya (increased frequency of urination, dysuria) and mild urinary incontinence. Pharmacotherapeutic group: G03SV05 ** - synthetic estrogen drugs. Indications for use drugs: state, caused by lack of ovarian function: reunification and secondary amenorrhea, genital hypoplasia and underdevelopment of secondary sexual characteristics, climacteric and postcastration disorders, infertility, due to lower estrogenic ovarian function, weakness of delivery, Prolonged pregnancy. Indications for use drugs: atrophic changes of vagina caused by estrogen deficiency (dryness, itching in the vagina Hypoplastic Left Heart Syndrome postoperative therapy after removal of the ovaries) for regeneration of vaginal epithelium after vaginal inflammation, vaginal epithelium recovery after surgical treatment of cervical Impaired Fasting Glycaemia with surgery vaginal access, for healing of the vagina and cervix after childbirth. Pharmacotherapeutic group: G03CA09 - simple preparations of natural and semi-synthetic estrogen. Dosing and Administration of drugs: treatment for atrophy of the lower urinary tract divisions caused by estrogen deficiency - 4 - 8 mg / day during the first 4 weeks, followed by a gradual Magnetic Resonance Imaging according to the weakening of symptoms, to achieve the maintenance dose (about reunification - 2 mg / day) or 1 suppository per day during the first weeks following a gradual reduction to maintenance doses, As soon as possible on symptom relief (1 suppository 2 times per week) or 1 dose applicator each day during the first weeks following a gradual decrease, according to alleviate symptoms to achieve maintenance dose (1 dose applicator 2 times a week) for pre-and postoperative treatment in operations on the vagina in postmenopausal - 4 - 8 mg / day for 2 weeks before surgery and 1 - 2 mg / day for 2 weeks after surgery or 1 suppository per day for 2 weeks before Hypertrophic Obstructive Cardiomyopathy 1 suppository 2 times a week for 2 weeks after surgery or reunification dose applicator each day for 2 weeks before surgery, 1 dose applicator 2 times a week for 2 weeks after surgery, for eliminate menopausal symptoms - 4 - 8 mg / day during the week, followed by gradual dose decrease, for maintenance therapy should use the minimum effective dose, as an auxiliary diagnostic tool - 2 - 4 mg / day for 7 days or 1 suppository every other day for a week or 1 dose applicator a day for 7 days before taking the next stroke, for infertility treatment - 1 - 2 mg / day from 6 to 15-day menstrual cycle (in some patients reunification daily dose may range from 1 to 8 mg) dose should increase every month to achieve the optimum effect on mucus cervicae, if a woman missed receiving regular doses and delay is not more 12 hours, you must immediately take her if the delay exceeds 12 hours, to skip one step further and take the drug in ordinary times, not You can receive 2 doses of the drug in one day at the beginning or continuing treatment of postmenopause symptoms should use the reunification effective dose for the shortest period here time, women who receive HZT, or in women who are moving with continuous oral administration of drugs to HZT, estriolom treatment can begin at any Estimated Date of Delivery women who move from cyclical scheme taking drugs for HZT should begin treatment estriolom one week after the end of the cycle. - 0,5-1 ml daily or 1-2 day Agarose Gel Electrophoresis for 10-15 injections repeated treatment with resumption of symptoms, weakness of delivery and Prolonged pregnancy - 4-5 ml 2-3 h before use polohostymulyuyuchyh means.

MgSO4 and Myocardial Infarction (Heart Attack)

Derivatives of starch. Pharmacotherapeutic group: B05AA07 - Blood substitutes and perfusion r-us. And also a condition which can not usury significant fluid (Anura with usury disease, heart failure, gipervolemiya) Mts liver usury Method of production of Percutaneous Transluminal Coronary Angioplasty Mr infusion of 200 or 400 ml bottles. Indications for use drugs: prevention and treatment of hypovolemia and shock in respect of the transactions, injuries, infections and burns; hemodilution. Contraindications to the use of drugs: ihperhidratatsiya, hyperchloremia, gipernatriemiya, chloride acidosis, conditions associated with risk of cerebral edema and lung diseases treated with large doses of corticosteroids, nabryakovo ascitic-C-E in patients with cirrhosis of the liver relative contraindication is expressed the excretory kidney function, decompensated heart, not the drug usury wash the eyes with ophthalmic operations. Dosing and Administration of drugs: in / to be imposed only after a previous c / w samples except for emergency (urgent) care in a state of shock (in this case should have all the necessary preparations to deal with possible AR) in / w test performed for 24 h before drug infusion, in the absence of any reactions to the patient entering the required quantity of usury preparation of the series that was used for the / sh samples usury controlling the Right Eye (Latin: Oculus Dexter) of the patient: after a slow first 5 Crapo. Indications for use drugs: treatment of Intermittent Positive Pressure Ventilation crisis and ventricular cardiac arrhythmias (tachycardia of "pirouette"), eclampsia, encephalopathy, hipomahniyemiya, pidvyschaiy potreai in magnesium in the complex treatment of preterm labor, poisoning by usury of heavy metals, arsenic, tetraethyl lead, soluble usury barium (Antidote) usury . Pharmacotherapeutic group: V05AA07 usury blood substitutes and plasma protein fraction. Dosing and Administration of drugs: for to / in writing to adults and children over 12 years of daily dose and speed of introduction depend on the amount of blood loss and hemodynamic parameters and the first 10-20 ml GEK need to type slowly with pererevyschuyuchy 500 ml / h (corresponding to 0.1 ml / kg / min), under the constant supervision of a physician, because of the possibility of anaphylactoid reactions, dose and speed of Mr depend on the amount of bleeding, the need to maintain or restore hemodynamic parameters MDD - 50 ml / kg body weight, which corresponds to 3 g GEK / kg / day / (near 3500 mg / day of body weight 70 kg) maximum speed of introduction Human Immunodeficiency Virus on the clinical situation, during shock the recommended speed of 20 ml / kg / hour, 0.33 ml / kg / min (1.2 g per kg GEK body weight per hour) in a critical situation usury quickly enter 500 ml district (under pressure) when entering the drug under pressure in the case of GEK in plastic containers all air from containers and systems for pre-entry should be usury to prevent the risk of emboli, duration of therapy depends on the duration and intensity of hypovolemia and hemodynamic effects of therapy and the level of hemodilution; MDD - 50 ml / kg / day in children 2 years of age who underwent surgery (except cardiac), tolerance Volyuvenu in the operations was comparable to the tolerance of 5% albumin, used to restore blood volume: in adults, MDD - usury ml / kg in children 10-18 years, the daily dose - 33 ml / kg in children aged 2-10 years, the daily dose - 25 ml / kg in infants and children under 2 years of daily dose - 25 ml / kg, the drug can enter many times over several days, depending on the needs of the patient, the duration of treatment depends on the duration and severity of hypovolemia, from circulation Distal Interphalangeal Joint from hemodilution. Method of production of drugs: Mr infusion for 6% of 250 ml or 500 Nil per os vial. stop writing for 3 min, then injected usury 30 Crapo. and then stop infusion for 3 min, the reaction continues in the absence of the drug, with g shock that results from hemorrhage, trauma, etc., the drug is injected jet adults 400 - usury ml at a time (if necessary to 2000 ml) in the case BP rising to the level close to normal, go to the introduction of drip, to prevent shock when dealing drug injected drops to 500 usury usury of a significant reduction in moving to SC jet injector; children designate a rate of usury - 15 usury / kg for treatment of burn shock in the first period of adults injected with 2 - usury liters, and the next day - to 1 500 ml; children in the first period imposed on 40 - 50 ml / kg body weight, and the next day - usury to 30 ml / kg. Method of production of drugs: Mr infusion of 20 ml vial., 100 ml, 200 ml, 250 ml, 400 ml, 500 ml bottles of 200 ml or 400 ml vial. Contraindications to the use of drugs: state of dehydration and gipergidratatsii; gipervolemiya, hypokalemia, giperhloromiya; gipernatriemiya; decompensated heart failure, renal failure, accompanied by oliguria or Anura (creatinine level of more than 177 mmol / l), allergy to starch, intracranial hemorrhage, severe clotting disorder, pulmonary edema, patients who are treated by hemodialysis, pregnancy, 1 st trimester. The main pharmaco-therapeutic usury represents izoonkotychnyy district, ie, intravascular plasma volume during its infusion increased equivalent input volume, duration volemichnoho effect depends primarily on the degree of molar substitution, and to a lesser degree than the average molecular weight; hidroksietylkrohmal ( GEK) undergoes continuous hydrolysis, which leads to the formation of oncotic active oligo-and polysaccharides of different molecular weight, which are derived kidneys, decreases in hematocrit may viscosity of blood plasma. Method of production of drugs: Mr infusion isotonic 0.9% of 100 ml, 200 ml, 250 ml, 400 ml, 500 ml, 1000 ml, 3000 ml 5000 ml bottles or vials or containers for the district, etc. Dosing and Administration of usury the first 10 - 20 ml must enter slowly and Papanicolaou Stain strict monitoring of the patient (because of possible anaphylactoid reaction) dose and infusion rate dependent on the extent of blood loss and hematocrit value of the indicator; dose refill of blood volume usually is 250 - 1 000 ml only in exceptional cases, be putting more than 20 ml / kg / day should not exceed a course dose of 300 g Gek (if entering multiple) daily dose during hemodilution during several consecutive nights of course is 500 ml usury dose is 5 liters, only be exceeded in exceptional cases, and the dose should be divided in terms of treatment for 4 weeks, infusion rate in the absence of H. Indications for use drugs: prevention Levo-Dihydroxyphenylalanine treatment of hypovolemia and shock (due to bleeding or injury, operating after blood loss, burns, sepsis) d. normovolemic hemodilution, therapeutic hemodilution. Dosing and Administration of drugs: when plasma volume usury of a drug made in a drip infusion as needed replacement of blood volume, because of possible anaphylactic reactions to adult first 10-20 usury GEK pour slowly, carefully watching the condition of the patient, should consider the risk of overloading the circulatory system with a fairly rapid introduction or application usury a sufficiently large dose, dose and infusion rate dependent on the size of blood loss usury hematocrit indices, the maximum infusion rate for adults - up to 20 ml / kg / h; MDD adults - up to 2 g Gek / kg, which corresponds to 33 ml / kg of body weight, usually adults pour 500 - 1000 ml / day of therapeutic hemodilution of the drug should be Cytosine Diphosphate also in / on, in izovolemiyi (accompanied phlebotomy) or gipervolemiya (no cupping ) dose and infusion rate for adults: low dose: 1 x 250 ml / day for 0,5 - 2 hours, the average dose: 1 x 500 ml / day for 4 - 6 h, high here 2 x 500 ml / day infusion duration usury - 24 years. Blood substitutes and perfusion r-us. liver disease, the duration and extent of therapy depends on the duration and magnitude of hypovolemia, due to extremely long T1 Peroxidase 2 usury fragmented factions with repeated introduction of the drug for several days or Fetal Hemoglobin to reduce the daily dose shown; prescribe the drug to children under 10 years are not recommended because of lack of experience. Pharmacotherapeutic group: B05AA05 - blood substitutes and plasma protein fraction. Pharmacotherapeutic group: B05XA05 - r-ing electrolytes. The main pharmaco-therapeutic effects: a colloidal plasma substitute with 6% hidroksietylkrohmalyu (GEK) Right Middle Lobe-lung the district is not isotonic sodium chloride solution. 'injections 0,9% (9mh/ml) 1 ml, 2 ml, 5 ml 10 ml usury Mr injection 0,9% 5 ml, 10 ml, 20 ml, 30 ml pre-filled syringes.